Bisogno, T.
114  Ergebnisse:
Personensuche X
?
 
?
2

The endocannabinoid system: possible new pharmacological ta..:

Collu, R. ; Scherma, M. ; Satta, V....
European Neuropsychopharmacology.  26 (2016)  - p. S129 , 2016
 
?
4

Control of experimental spasticity by targeting the degrada..:

Pryce, G ; Cabranes, A ; Fernández-Ruiz, J...
Multiple Sclerosis Journal.  19 (2013)  14 - p. 1896-1904 , 2013
 
?
 
?
7

Endogenous Cannabinoids: Structure and Metabolism:

Bisogno, T.
Journal of Neuroendocrinology.  20 (2008)  s1 - p. 1-9 , 2008
 
?
8

Metabolically labile cannabinoid esters: A 'soft drug' appr..:

Minutolo, F. ; Cascio, M.G. ; Carboni, I....
Bioorganic & Medicinal Chemistry Letters.  17 (2007)  17 - p. 4878-4881 , 2007
 
?
9

In vitro and in vivo pharmacology of synthetic olivetol‐ or..:

Cascio, M G ; Bisogno, T ; Palazzo, E...
British Journal of Pharmacology.  149 (2006)  4 - p. 431-440 , 2006
 
?
10

The endocannabinoid signalling system: Biochemical aspects:

BISOGNO, T ; LIGRESTI, A ; DIMARZO, V
Pharmacology Biochemistry and Behavior.  81 (2005)  2 - p. 224-238 , 2005
 
?
11

Up-regulation of the endocannabinoid system in the uterus o..:

Maccarrone, M. ; Fride, E. ; Bisogno, T....
MHR: Basic science of reproductive medicine.  11 (2005)  1 - p. 21-28 , 2005
 
?
12

Dual effect of cannabinoid CB 1 receptor stimulation on a v..:

Hermann, H. ; De Petrocellis, L. ; Bisogno, T....
Cellular and Molecular Life Sciences (CMLS).  60 (2003)  3 - p. 607-616 , 2003
 
?
13

Anandamide receptors:

Di Marzo, V. ; De Petrocellis, L. ; Fezza, F...
Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA).  66 (2002)  2-3 - p. 377-391 , 2002
 
?
 
?
 
1-15